Effects of Modified Danggui Beimu Kushen Pill on the Expressions of VEGFA, MMP13 and TGF-β in Tumor Tissues of MFC Gastric Cancer Bearing Mice

Xiaoming FAN,Yu ZHAI,Xia AN,Hongyan WU,Hailong LI
DOI: https://doi.org/10.19664/j.cnki.1002-2392.180109
2018-01-01
Abstract:Objective: To study the effects of Modified Danggui Beimu Kushen Pill on the expressions of VEGFA, MMP13 and TGF-β in tumor tissues of MFC gastric cancer bearing mice. Methods: MFC gastric cancer bearing mice were em-ployed to perform anti -tumor experiment in vivo. A total of 48 eligible mice were randomly divided into the model group, DDP group, low-dose group of Modified Danggui Beimu Kushen Pill, high-dose group of Modified Danggui Beimu Kushen Pill, DDP combined with low-dose group, and DDP combined with high-dose group. The treatment course was 14 continuous days. After the last treatment, all mice were killed to obtain complete tumor tissue for further detection of VEGFA, MMP13 and TGF-β with the method of RT-qPCR and immunohistochemistry. Results: RT-qPCR detection showed that the expressions of VEGFA, MMP13 and TGF-β mRNA in each medication group were de-creased compared to those in the model group(P<0.05). Immunohistochemical detection showed that the expressions of VEGFA, MMP13 and TGF-β were less colored and with weakly positive expression in the combined group, compared to DDP group and Chinese medication groups. Conclusion: Modified Danggui Beimu Kushen Pill can down-regulate the expressions of VEGFA, MMP13 and TGF-β of tumor tissue in MFC gastric cancer bearing mice to play anti-tumor role.
What problem does this paper attempt to address?